3966.08B
Market cap
47.31x
Current P/E
37.31x
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases.

Similar securities

Based on sector and market capitalization

Report issue